Crawford Lake Capital Management, LLC Fate Therapeutics Inc Transaction History
Crawford Lake Capital Management, LLC
- $0
- Q1 2023
A detailed history of Crawford Lake Capital Management, LLC transactions in Fate Therapeutics Inc stock. As of the latest transaction made, Crawford Lake Capital Management, LLC holds 58,600 shares of FATE stock, worth $157,048. This represents 0.12% of its overall portfolio holdings.
Number of Shares
58,600Holding current value
$157,048% of portfolio
0.12%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding FATE
# of Institutions
184Shares Held
123MCall Options Held
15KPut Options Held
14K-
Redmile Group, LLC San Francisco, CA13.2MShares$35.3 Million2.82% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.6MShares$28.3 Million0.0% of portfolio
-
Black Rock Inc. New York, NY10.1MShares$27.1 Million0.0% of portfolio
-
Boxer Capital, LLC San Diego, CA8.22MShares$22 Million1.5% of portfolio
-
Deep Track Capital, LP Greenwich, CT5.57MShares$14.9 Million0.6% of portfolio
About FATE THERAPEUTICS INC
- Ticker FATE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 97,000,304
- Market Cap $260M
- Description
- Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...